Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
TwinStrand Biosciences, Inc. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners but 1 distinct art unit, so examiner assignments vary within a common art-unit setting.
GRAY, JESSICA is the busiest examiner, with 1 pending office action. Counsel can use the shared art-unit context for consistency while preparing separate responses for the individual examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRAY, JESSICA | 1 | 0.0% | +0.0% |
| TURPIN, ZACHARY MARK | 1 | 4.0% | -5.0% |
| HANEY, AMANDA MARIE | 1 | 36.5% | +45.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17607490 | METHODS AND REAGENTS FOR NUCLEIC ACID SEQUENCING AND ASSOCIATED APPLICATIONS | TURPIN, ZACHARY MARK | 12d |
| 18347413 | REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS | GRAY, JESSICA | — |
| 16969531 | METHODS AND REAGENTS FOR DETECTING AND ASSESSING GENOTOXICITY | HANEY, AMANDA MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16969531 | METHODS AND REAGENTS FOR DETECTING AND ASSESSING GENOTOXICITY | HANEY, AMANDA MARIE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18347413 | REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS | GRAY, JESSICA | 1682 | §103§112 | Non-Final OA | — | Pending | Jul 05, 2023 |
| 17607490 | METHODS AND REAGENTS FOR NUCLEIC ACID SEQUENCING AND ASSOCIATED APPLICATIONS | TURPIN, ZACHARY MARK | 1682 | §103Other | Final Rejection | 12d | Pending | Oct 29, 2021 |
| 16969531 | METHODS AND REAGENTS FOR DETECTING AND ASSESSING GENOTOXICITY | HANEY, AMANDA MARIE | 1682 | §101§103 | Final Rejection | — | Pending | Dec 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTwinStrand Biosciences, Inc. has 3 pending office actions as of October 2026, spread across 1 art units and 3 examiners.
Jessica Gray has the most, with 1 of TwinStrand Biosciences, Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
